Diabetes Mellitus Type 1 study: Healthy Living
Official title CBTi for the Treatment of Insomnia in Type 1 Diabetes
ClinicalTrials.gov ID: NCT07091318
What this study is testing
- What it's testing
- The study wants to see if a virtual cognitive‑behavioral sleep program can improve sleep, blood‑sugar control, mood and fatigue compared with general health education.
- Who it's for
- Adults who have type 1 diabetes and trouble sleeping (insomnia).
- What's involved
- You will join either eight Zoom sessions with a therapist or receive weekly health emails and brief coach calls, wear a sleep‑tracking watch for two weeks, share continuous glucose data, and fill out questionnaires.
- Time commitment
- The study lasts 12 weeks and includes three in‑person clinic visits plus the virtual sessions or calls.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Between 18 to 65 years old
- Have been diagnosed with Type 1 Diabetes for at least a year
- Use a continuous glucose monitor
- Have poor sleep quality
- Able to attend 3 office visits
You likely can't join if
- Currently or planning pregnancy or breast feeding
- Employed with a rotating or night shift
- Are at a high risk for obstructive sleep apnea
- Non-English speaking (unable to participate in therapy or questionnaire).
- Take medications for sleep
- moderately severe to severe depression
See the full eligibility criteria
- Between 18 to 65 years old
- Have been diagnosed with Type 1 Diabetes for at least a year
- Use a continuous glucose monitor
- Have poor sleep quality
- Able to attend 3 office visits
- Currently or planning pregnancy or breast feeding
- Employed with a rotating or night shift
- Are at a high risk for obstructive sleep apnea
- Non-English speaking (unable to participate in therapy or questionnaire).
- Take medications for sleep
- moderately severe to severe depression
- Have a significant medical history that includes conditions like heart failure, cirrhosis, COPD, diseases requiring oxygen, active treatment for cancer or psychiatric problems, history of stroke with neurological...
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.